SUBCUT HF II is a multicenter, open-label, randomized controlled investigator-sponsored clinical trial that compared at-home treatment ...
Five-year collaboration framework aims to advance point-of-care diagnostics, clinical performance evaluation, and precision-medicine applications...
The goal is to help researchers move faster from prediction to experimental evidence, creating a continuous learning cycle ...
Feng Ren discusses AI’s impact on target discovery, R&D productivity and clinical development, and Asia’s role in translating computational predictions into new medicines....
Expanded Broadens Use of ALZpath's Proprietary pTau217 Antibody Technology across the Quanterix Simoa Research Portfolio...
The Class II decision-support software analyses lung sound recordings from compatible FDA-cleared electronic stethoscopes and flags recordings suggestive of wheeze for clinical review....
Pressure Points is the result of Angel's ongoing research initiatives, which concentrate on improving clinical predictability and effectiveness...
Peer-reviewed research reports the first human proof-of-concept evidence of a technology intentionally designed to capture microplastics...
Terumo Blood and Cell Technologies’ Hidden Struggle barometer compares seven European health systems on treatment access, workforce training, registries, newborn screening and national coordination....
The study describes how cells rapidly transport cholesterol to lysosomal membranes when these organelles take in damaged mitochondria...
